1. < Home

SARS-CoV-2

Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial

Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B, Gebo K, Cachay E, Kassaye SG, Paxton JH, Gerber J, Levine AC, Naeim A, Currier[...]

By sjmartinez • February 11, 2023
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants

Junker D, Becker M, Wagner TR, Kaiser PD, Maier S, Grimm TM, Griesbaum J, Marsall P, Gruber J, Traenkle B, Heinzel C, Pinilla YT, Held[...]

By sjmartinez • February 11, 2023
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial

Boulware DR, Murray TA, Proper JL, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Siegel LK, Klatt NR, Odde[...]

By sjmartinez • February 11, 2023
The role of oxidative stress in the pathogenesis of infections with coronaviruses

Gain C, Song S, Angtuaco T, Satta S, Kelesidis T. The role of oxidative stress in the pathogenesis of infections with coronaviruses. Front Microbiol. 2023[...]

By sjmartinez • January 31, 2023
Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study

Gottlieb M, Wang R, Yu H, Spatz ES, Montoy JC, Rodriguez R, Chang AM, Elmore JG, Hannikainen PA, Hill M, Huebinger RM, Idris AH, Lin[...]

By sjmartinez • January 28, 2023
Three-month symptom profiles among symptomatic adults with positive and negative SARS-CoV-2 tests: a prospective cohort study from the INSPIRE group

Spatz ES, Gottlieb M, Wisk LE, Anderson J, Chang AM, Gentile NL, Hill MJ, Huebinger RM, Idris AH, Kinsman J, Koo K, Li SX, McDonald[...]

By sjmartinez • December 28, 2022
Iodine contrast exposure and incident COVID-19 infection

Tsai K, Inoue K, McClean M, Kaunitz JD, Akiba Y, Lee ML, Neverova NV, Currier JW, Ebrahimi R, Bashir MT, Leung AM. Iodine contrast exposure[...]

By sjmartinez • December 20, 2022
A national survey of early treatment seeking behavior among those with incident SARS-CoV-2 infection

Kojima N, Brobeck M, Slepnev V, Klausner JD. A national survey of early treatment seeking behavior among those with incident SARS-CoV-2 infection. Respir Med Res.[...]

By sjmartinez • December 6, 2022
Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses

Ibarrondo FJ, Hofmann C, Fulcher JA, Goodman-Meza D, Mu W, Hausner MA, Ali A, Balamurugan A, Taus E, Elliott J, Krogstad P, Tobin NH, Ferbas[...]

By sjmartinez • November 11, 2022
Using time-weighted average change from baseline of SARS-CoV-2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID-19

Kumbhakar R, Neradilek M, Barnabas RV, Stewart J, Stankiewicz Karita HC, Landovitz RJ, Kissinger PJ, Jerome KR, Paasche-Orlow MK, Bershteyn A, Chu HY, Neuzil KM,[...]

By sjmartinez • October 18, 2022